Moolec Science S.A.
MLEC · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $312 | $340 | $402 | $506 |
| - Cash | $2 | $4 | $5 | $4 |
| + Debt | $22 | $22 | $15 | $14 |
| Enterprise Value | $332 | $358 | $411 | $516 |
| Revenue | $3 | $2 | $2 | $2 |
| % Growth | 69.7% | 2.2% | -27.8% | – |
| Gross Profit | -$1 | $0 | -$0 | $0 |
| % Margin | -25.5% | 0.9% | -4.7% | 4.3% |
| EBITDA | -$1 | -$1 | -$2 | -$1 |
| % Margin | -43.6% | -68.6% | -155.3% | -29.7% |
| Net Income | -$2 | -$2 | -$3 | -$1 |
| % Margin | -91.8% | -123% | -166.5% | -66.5% |
| EPS Diluted | -0.06 | -0.05 | -0.07 | -0.04 |
| % Growth | -20% | 28.6% | -75% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$3 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$3 |